In order to further streamline scheduling and reduce operational costs for healthcare facilities, ShiftMed and UKG have announced a technology partnership ShiftMed, the first on-demand workforce platform that offers scalable, affordable, and sustainable labour across the full spectrum of care settings—from health system acute and outpatient settings to post-acute and […]
Featured News
Missing Data From Rapid MRI Scans is Reconstructed by Artificial Intelligence
Artificial Intelligence Reconstructs Missing Data From Rapid MRI Scans According to a recent study by the NYU Grossman School of Medicine and Meta AI Research, artificial intelligence (AI) is capable of reconstructing rapidly performed, coarsely sampled magnetic resonance imaging (MRI) scans into high-quality images with comparable diagnostic value as those […]
Merck Selects Perceiv AI for Inaugural Digital Sciences Studio Cohort
Perceiv AI declared that Merck had chosen it and eight other early-stage biomedical businesses from a pool of 152 applications for the first cohort of the Merck Digital Sciences Studio (MDSS). The program was launched in November to support cutting-edge digital technology for drug research. “Being selected for the Merck […]
Amcor Expands Healthcare Platform In The Asia Pacific Region With Acquisition Of MDK
Amcor, a pioneer in responsible packaging solutions development and production, announced today that it has reached an agreement to buy Shanghai-based MDK. MDK, a market leader in medical device packaging and a key priority growth area for Amcor, has annual sales of about $50 million. Amcor’s existing portfolio is enhanced […]
Bioarctic’s Partner Eisai Submits Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer’s Disease In Japan
A marketing authorization application for lecanemab, an investigational anti-amyloid beta (A) protofibril antibody, has been submitted by BioArctic AB’s (publ) partner Eisai to the Pharmaceuticals and Medical Devices Agency for the treatment of mild cognitive impairment (MCI) brought on by Alzheimer’s disease (AD) and mild Alzheimer’s dementia (collectively known as […]
Autolomous aims to provide digital solutions to Centers for Breakthrough Medicines to streamline and automate cell and gene therapy manufacturing
The US Center for Breakthrough Medicines (CBM), a Cell and Gene Therapy Contract Organization for Development, Manufacturing, and Testing, has entered into a licencing agreement with Autolomous LTD, the market-leading developer of critical manufacturing management systems for cell and gene therapies (CGT) (CDMO). With the help of the agreement, Autolomous […]
Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of New Mexicans
Representative Christine Chandler (D-Los Alamos), who has partnered with Susan G. Komen to introduce legislation that would eliminate financial restrictions on imaging that can rule out breast cancer or confirm the need for a biopsy, is commended by Komen. Komen is the world’s largest breast cancer organisation. In New Mexico, […]
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
The life sciences toolmaker Berkeley Lights, Inc. announced the release of Beacon SelectTM, a new optofluidic system for cell line development (CLD). The Beacon Select expands upon the cutting-edge technology provided by the original Beacon system, which was introduced in 2017 and has more than 130 systems already placed throughout […]
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases
Ipsen and Albireo declared today that they have signed a binding merger agreement under which Ipsen would buy Albireo, a pioneer in the development of bile-acid modulators for the treatment of cholestatic liver disorders in both children and adults. The upcoming acquisition will improve Ipsen’s pipeline and portfolio for rare […]
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
It was disclosed that BWXT Medical Ltd., a division of BWX Technologies, Inc., and Fusion Pharmaceuticals Inc. had signed a preferred partner agreement for the delivery of actinium-225. According to the contract, BWXT Medical will supply Fusion with defined volumes of actinium at volume-based prices. An alpha-emitting isotope called actinium-225 […]
